Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Soft Tissue Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01898663
What this trial is testing

DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With AML

Who this might be right for
High-risk Soft Tissue Sarcoma
Affiliated Hospital to Academy of Military Medical Sciences 30
Early research (Phase 1)Study completedNCT04052334
What this trial is testing

Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma

Who this might be right for
Sarcoma
H. Lee Moffitt Cancer Center and Research Institute 9
Testing effectiveness (Phase 2)Looking for participantsNCT06736613
What this trial is testing

Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaStage III High Grade B-Cell Lymphoma+7 more
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)UnknownNCT03475953
What this trial is testing

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Who this might be right for
Colorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more
Institut Bergonié 747
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Not applicableNot Yet RecruitingNCT06726512
What this trial is testing

Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy

Who this might be right for
Oral CancerOsteosarcomaSoft Tissue Sarcoma+1 more
University Medical Center Groningen 30
Testing effectiveness (Phase 2)Study completedNCT00592345
What this trial is testing

High-Dose Proton/Photon RT + Surgery of Sarcomas of the Thoracic, Lumbar Spine/Sacrum

Who this might be right for
Mesenchymal Tumor
Massachusetts General Hospital 50
Early research (Phase 1)Study completedNCT00007813
What this trial is testing

Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+5 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21
Large-scale testing (Phase 3)Study completedNCT02711007
What this trial is testing

Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy

Who this might be right for
OsteosarcomaMetastasis
GUO WEI 37
Not applicableLooking for participantsNCT07432932
What this trial is testing

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

Who this might be right for
SarcomaSarcoma, Leiomyo-, AdultSarcoma, Synovial, Adult+9 more
Royal Marsden NHS Foundation Trust 800
Testing effectiveness (Phase 2)Looking for participantsNCT06835049
What this trial is testing

Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE)

Who this might be right for
Sarcoma,Soft Tissue
Swiss Cancer Institute 24
Testing effectiveness (Phase 2)UnknownNCT04351308
What this trial is testing

Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma

Who this might be right for
OsteosarcomaSurvivalChemotherapy Effect+1 more
Peking University People's Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT01659203
What this trial is testing

Proton or Photon RT for Retroperitoneal Sarcomas

Who this might be right for
Retroperitoneal Sarcoma
Massachusetts General Hospital 80
Not applicableUnknownNCT01758666
What this trial is testing

A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX Therapy

Who this might be right for
Osteosarcoma
Tianjin Medical University Cancer Institute and Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00027937
What this trial is testing

Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT05262101
What this trial is testing

Clinical Trial of TQB2858 Injection in the Treatment of Advanced High-grade Sarcoma

Who this might be right for
Advanced High-grade Sarcoma
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 7
Large-scale testing (Phase 3)Study completedNCT00116935
What this trial is testing

Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Sarcoma
Scandinavian Sarcoma Group 400
Testing effectiveness (Phase 2)Ended earlyNCT02022358
What this trial is testing

Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?

Who this might be right for
OsteosarcomaSpindle Cell Sarcoma of Bone
University College, London 34
Early research (Phase 1)Ended earlyNCT00623077
What this trial is testing

MT2004-30: Tomotherapy for Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsKidney CancerLiver Cancer+2 more
Masonic Cancer Center, University of Minnesota 23
Not applicableWithdrawnNCT01112800
What this trial is testing

Markers of Anthracycline-Related Cardiac Muscle Injury

Who this might be right for
OsteosarcomaEwing's Sarcoma Family of TumorsRhabdomyosarcoma+1 more
St. Jude Children's Research Hospital
Next Page